Anti-Müllerian Hormone promotes human osteoblast differentiation and calcification by modulating osteogenic gene expression

References

• Matsuo K, Irie N. Osteoclast–osteoblast communication. Arch Biochem Biophys. 2008;473(2):1–6. doi:10.1016/j.abb.2008.03.027.
   PubMed Web of Science ®Google Scholar
• Datta HK, Ng WF, Walker JA, et al. The cell biology of bone metabolism. J Clin Pathol. 2008;61(5):577–587. doi:10.1136/jcp.2007.048868.
   PubMed Web of Science ®Google Scholar
• Ponzetti M, Rucci N. Osteoblast differentiation and signaling: established concepts and emerging topics. Int J Mol Sci. 2021;22(13):6651. doi:10.3390/ijms22136651.
   PubMed Web of Science ®Google Scholar
• Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol. 2011;6(1):121–145. doi:10.1146/annurev-pathol-011110-130203.
   PubMedGoogle Scholar
• Shen Y, Huang X, Wu J, et al. The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019. Front Endocrinol. 2022;13:882241. doi:10.3389/fendo.2022.882241.
   PubMed Web of Science ®Google Scholar
• Jang S, Park C, Jang S, et al. Medical service utilization with osteoporosis. Endocrinol Metab. 2010;25(4):326–339. doi:10.3803/EnM.2010.25.4.326.
   Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733. doi:10.1007/s00198-006-0172-4.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int. 2005;16(S02):S3–S7. doi:10.1007/s00198-004-1702-6.
   PubMedGoogle Scholar
• Avioli LV. Senile and postmenopausal osteoporosis. Adv Intern Med. 1976;21:391–415.
   PubMedGoogle Scholar
• Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998;338(11):736–746. doi:10.1056/NEJM199803123381107.
   PubMed Web of Science ®Google Scholar
• Marie PJ, Kassem M. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol. 2011;165(1):1–10. doi:10.1530/EJE-11-0132.
   PubMed Web of Science ®Google Scholar
• Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5(11):898–907. doi:10.1016/S2213-8587(17)30188-2.
   PubMed Web of Science ®Google Scholar
• Jann J, Gascon S, Roux S, et al. Influence of the TGF-β superfamily on osteoclasts/osteoblasts balance in physiological and pathological bone conditions. Int J Mol Sci. 2020;21(20):7597. doi:10.3390/ijms21207597.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li M, Wang S, et al. Recent advances of osterix transcription factor in osteoblast differentiation and bone formation. Front Cell Dev Biol. 2020;8:601224. doi:10.3389/fcell.2020.601224.
   PubMed Web of Science ®Google Scholar
• Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108(1):17–29. doi:10.1016/s0092-8674(01)00622-5.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Otsuka F, Hino J, et al. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Mol Cell Endocrinol. 2012;350(1):78–86. doi:10.1016/j.mce.2011.11.023.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Kida K, Yamaguchi A, et al. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem. 2008;283(43):29119–29125. doi:10.1074/jbc.M801774200.
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002;124(5):601–609. doi:10.1530/rep.0.1240601.
   PubMed Web of Science ®Google Scholar
• Josso N, di Clemente N. Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-β family. Trends Endocrinol Metab. 2003;14(2):91–97. doi:10.1016/s1043-2760(03)00005-5.
   PubMed Web of Science ®Google Scholar
• Mullen RD, Wang Y, Liu B, et al. Osterix functions downstream of anti-Müllerian hormone signaling to regulate müllerian duct regression. Proc Natl Acad Sci U S A. 2018;115(33):8382–8387. doi:10.1073/pnas.1721793115.
   PubMed Web of Science ®Google Scholar
• Baarends WM, Van Helmond MJ, Post M, et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development. 1994;120(1):189–197. doi:10.1242/dev.120.1.189.
   PubMed Web of Science ®Google Scholar
• Kim JH, Yang YR, Kwon KS, et al. Anti-Müllerian hormone negatively regulates osteoclast differentiation by suppressing the receptor activator of nuclear factor-κB ligand pathway.J Bone Metab. 2021;28(3):223–230. (doi:10.11005/jbm.2021.28.3.223.
   PubMedGoogle Scholar
• Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 1997;21(1):A-3B.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508–1514. doi:10.1126/science.289.5484.1508.
   PubMed Web of Science ®Google Scholar
• Howard JA, Hart KN, Thompson TB. Molecular mechanisms of AMH signaling. Front Endocrinol. 2022;13:927824. doi:10.3389/fendo.2022.927824.
   PubMed Web of Science ®Google Scholar
• Cate RL. Anti-Müllerian hormone signal transduction involved in müllerian duct regression. Front Endocrinol. 2022;13:905324. doi:10.3389/fendo.2022.905324.
   PubMed Web of Science ®Google Scholar
• Zou ML, Chen ZH, Teng YY, et al. The smad dependent TGF-β and BMP signaling pathway in bone remodeling and therapies. Front Mol Biosci. 2021;8:593310. 5doi:10.3389/fmolb.2021.593310.
   PubMed Web of Science ®Google Scholar
• Murshed M. Mechanism of bone mineralization. Cold Spring Harb Perspect Med. 2018;8(12):a031229. doi:10.1101/cshperspect.a031229.
   PubMed Web of Science ®Google Scholar
• Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006;99(5):1233–1239. doi:10.1002/jcb.20958.
   PubMed Web of Science ®Google Scholar